Tempest Therapeutics, Inc. Restructuring Reserve
Tempest Therapeutics, Inc. (TPST) had Restructuring Reserve of $47.00 thousand as of 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Balance Sheet › Liabilities
us-gaap:RestructuringReserve · last filed 2018-11-09
- 2018-09-30: Restructuring Reserve $47.00K.
- 2018-06-30: Restructuring Reserve $513.00K.
- 2018-03-31: Restructuring Reserve $451.00K.
- 2017-12-31: Restructuring Reserve $403.00K.
| Period end | Restructuring Reserve |
|---|---|
| 2018-09-30 | $47.00K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $513.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $451.00K 10-Q · filed 2018-05-03 |
| 2017-12-31 | $403.00K 10-Q · filed 2018-11-09 |
| 2017-09-30 | $1.25M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $2.47M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $2.63M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $3.41M 10-K · filed 2018-03-15 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |